Expired CME Article

Severe Acute Respiratory Syndrome: An Overview

Authors: Fares J. Khater, MD, Jonathan P. Moorman, MD

Abstract

Severe acute respiratory syndrome (SARS) is a severe pulmonary infection that has been identified in multiple outbreaks around the world after emerging from mainland China in early 2003. The syndrome is caused by SARS-associated coronavirus, a novel human infection. SARS-associated coronavirus is spread by multiple mechanisms, including direct contact and large-droplet aerosolization, and may be spread by droplet nuclei as well. Clinical disease is characterized by fever, dry cough, interstitial infiltrates, and variable progression to respiratory failure. No treatment has clearly been shown to be effective. Aggressive infection control measures to prevent viral spread are key to outbreak management.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. World Health Organization. Communicable Disease Surveillance & Response (CSR): Severe Acute Respiratory Syndrome (SARS)—WHO guidelines/recommendations/descriptions. Available at:http://www.who.int/csr/sars/guidelines/en/. Accessed July 15, 2003.
 
2. Centers for Disease Control and Prevention. Update: Severe acute respiratory syndrome—United States, June 18, 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 24): 570.
 
3. Centers for Disease Control and Prevention. Update: Severe acute respiratory syndrome—Toronto, Canada, 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 23): 547–550.
 
4. Centers for Disease Control and Prevention. Cluster of severe acute respiratory syndrome cases among protected health-care workers: Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 19): 433–436.
 
5. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003; 300: 1961–1966.
 
6. Dye C, Gay N. Epidemiology: Modeling the SARS epidemic. Science 2003; 300: 1884–1885 (comment).
 
7. Centers for Disease Control and Prevention. Severe acute respiratory syndrome: Singapore, 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 18): 405–411.
 
8. Centers for Disease Control and Prevention. Severe acute respiratory syndrome: Taiwan, 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 20): 461–466.
 
9. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1977–1985.
 
10. Peiris JS, Chu CM, Cheng VC, et al; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet 2003; 361: 1767–1772.
 
11. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801–2809.
 
12. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986–1994.
 
13. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS) and coronavirus testing: United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 14): 297–302.
 
14. Centers for Disease Control and Prevention. Updated interim surveillance case definition for severe acute respiratory syndrome (SARS): United States, April 29, 2003. MMWR Morb Mortal Wkly Rep 2003; 52( 17): 391–393.